Charles Schwab Investment Management Inc Avidity Biosciences, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 990,182 shares of RNA stock, worth $31.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

990,182

Previous 793,117 24.85%

Holding current value

$31.6 Million

Previous $32.4 Million 40.38%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$37.21 - $48.14 $7.33 Million - $9.49 Million	197,065 Added 24.85%	990,182 $45.5 Million
Q2 2024 Aug 12, 2024	BUY	$22.73 - $40.85 $5.56 Million - $10 Million	244,682 Added 44.61%	793,117 $32.4 Million
Q1 2024 May 08, 2024	BUY	$9.16 - $25.52 $24,402 - $67,985	2,664 Added 0.49%	548,435 $14 Million
Q4 2023 Feb 06, 2024	BUY	$4.87 - $9.37 $149,382 - $287,415	30,674 Added 5.95%	545,771 $4.94 Million
Q3 2023 Nov 08, 2023	SELL	$6.3 - $11.35 $104,239 - $187,797	-16,546 Reduced 3.11%	515,097 $3.29 Million
Q2 2023 Aug 09, 2023	BUY	$10.62 - $17.34 $457,148 - $746,417	43,046 Added 8.81%	531,643 $5.9 Million
Q1 2023 May 11, 2023	BUY	$15.35 - $25.65 $380,357 - $635,581	24,779 Added 5.34%	488,597 $7.5 Million
Q4 2022 Feb 13, 2023	BUY	$10.06 - $22.66 $872,202 - $1.96 Million	86,700 Added 22.99%	463,818 $10.3 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $612,818 - $928,741	39,639 Added 11.75%	377,118 $6.16 Million
Q2 2022 Aug 15, 2022	BUY	$11.18 - $20.5 $421,228 - $772,378	37,677 Added 12.57%	337,479 $4.9 Million
Q1 2022 May 13, 2022	BUY	$14.2 - $23.78 $120,146 - $201,202	8,461 Added 2.9%	299,802 $5.54 Million
Q4 2021 Feb 11, 2022	BUY	$20.4 - $28.66 $162,996 - $228,993	7,990 Added 2.82%	291,341 $6.93 Million
Q3 2021 Nov 16, 2021	BUY	$18.16 - $25.21 $2.55 Million - $3.54 Million	140,392 Added 98.2%	283,351 $6.98 Million
Q2 2021 Aug 16, 2021	SELL	$19.62 - $29.26 $14,636 - $21,827	-746 Reduced 0.52%	142,959 $3.53 Million
Q1 2021 May 17, 2021	BUY	$20.28 - $28.15 $687,532 - $954,341	33,902 Added 30.88%	143,705 $3.14 Million
Q4 2020 Feb 16, 2021	BUY	$24.73 - $35.12 $47,852 - $67,957	1,935 Added 1.79%	109,803 $2.8 Million
Q3 2020 Nov 13, 2020	BUY	$23.35 - $35.94 $2.52 Million - $3.88 Million	107,868 New	107,868 $3.04 Million

Others Institutions Holding RNA

# of Institutions

252

Shares Held

107M

Call Options Held

224K

Put Options Held

161K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.66B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Avidity Biosciences, Inc. Transaction History